We are live on ! Find out more
KANG

iKang Healthcare Group, Inc.
KANG

Delisted

KANG was delisted on the 18th of January, 2019.

71 hedge funds and large institutions have $522M invested in iKang Healthcare Group, Inc. in 2015 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 15 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 11

42% more funds holding

Funds holding: 5071 (+21)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

17% more capital invested

Capital invested by funds: $445M → $522M (+$77M)

12% less call options, than puts

Call options by funds: $1.68M | Put options by funds: $1.91M

21% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 19

Holders
71
Holders Change
+21
Holders Change %
+42%
% of All Funds
1.91%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
33
Increased
15
Reduced
19
Closed
11
Calls
$1.68M
Puts
$1.91M
Net Calls
-$229K
Net Calls Change
-$3.62M
Name Holding Trade Value Shares
Change
Change in
Stake
CS
26
Credit Suisse
Switzerland
$2.45M +$1.36M +73,794 +139%
ZAM
27
Zenit Asset Management
Sweden
$2.29M +$2.2M +119,688 New
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$1.71M +$1.1M +59,694 +208%
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
$1.62M +$1.54M +83,921 New
Two Sigma Investments
30
Two Sigma Investments
New York
$1.59M +$1.2M +65,368 +385%
CPA
31
Columbia Pacific Advisors
Washington
$1.46M +$1.39M +75,498 New
Artisan Partners
32
Artisan Partners
Wisconsin
$1.45M +$283K +15,409 +26%
Invesco
33
Invesco
Georgia
$1.4M +$1.33M +72,197 New
RFC
34
Russell Frank Company
Washington
$1.3M +$1.29M +70,000 New
Morgan Stanley
35
Morgan Stanley
New York
$1.17M -$469K -25,494 -30%
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$1.1M -$42.1K -2,289 -4%
MYAM
37
Meiji Yasuda Asset Management
Japan
$1.06M +$1.01M +54,700 New
Mirae Asset Global Investments
38
Mirae Asset Global Investments
South Korea
$1.06M +$184K +10,000 +22%
BAMS
39
Bellevue Asset Management (Switzerland)
Switzerland
$967K +$919K +50,000 New
PHK
40
Point72 Hong Kong
Hong Kong
$967K +$919K +50,000 New
GAMA
41
Graticule Asia Macro Advisors
New York
$966K +$919K +50,000 New
GF
42
Gabelli Funds
New York
$932K -$355K -19,300 -29%
OCM
43
Oaktree Capital Management
California
$930K +$884K +48,100 New
BlackRock
44
BlackRock
New York
$924K +$878K +47,786 New
ACP
45
Ashfield Capital Partners
California
$810K -$17.1K -932 -2%
Fidelity Investments
46
Fidelity Investments
Massachusetts
$797K
Barclays
47
Barclays
United Kingdom
$760K +$735K +40,000 New
Deutsche Bank
48
Deutsche Bank
Germany
$576K -$225K -12,243 -29%
GP
49
GLG Partners
United Kingdom
$504K +$479K +26,039 New
CSS
50
Cubist Systematic Strategies
Connecticut
$431K +$409K +22,277 New

KANG Hedge Fund Activity: Q2 2015 in Review

71 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q2 2015, worth a combined $522M — up 17% from $445M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new KANG positions and 11 closed out — a net gain of 22 holders — while 15 added to existing stakes and 19 trimmed.

The largest buyer was Joho Capital, opening a new position worth an estimated $51.9M. The largest seller was Goldman Sachs, cutting an estimated $72.9M.

  • 71 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q2 2015, up from 50 in Q1 2015.
  • Funds reported $522M of iKang Healthcare Group, Inc. stock for Q2 2015, up 17% quarter-over-quarter.
  • 33 funds opened new iKang Healthcare Group, Inc. positions in Q2 2015 and 11 closed out, a net change of +22 holders.
  • The largest iKang Healthcare Group, Inc. buyer in Q2 2015 was Joho Capital, an estimated $51.9M added.
  • The largest iKang Healthcare Group, Inc. seller in Q2 2015 was Goldman Sachs, an estimated $72.9M sold.

Based on aggregated 13F filings for Q2 2015.